TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 22628060

Group type: EXPERIMENTAL
Intervention: EDOX+ENOX
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ENOX
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ENOX12-EDOX
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: EDOX
Number of subjects: 0
Study: 20448541

Group type: EXPERIMENTAL
Intervention: Group A (‐T, ‐E)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Group B (‐T, +E)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Group C (+T, ‐E)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Group D (+T, +E)
Number of subjects: 54
Study: 17376119

Group type: EXPERIMENTAL
Intervention: Topiramate treatment
Number of subjects: 67

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67
Study: 15721970

Group type: EXPERIMENTAL
Intervention: Tailored advice for hypertension management
Number of subjects: 767

Group type: COMPARATOR
Intervention: General health promotion advice
Number of subjects: 767
Study: 12194619

Group type: EXPERIMENTAL
Intervention: Holding a weighted spoon (248 g)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Holding a built-up spoon (108 g)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Holding a built-up spoon while wearing a weighted wrist cuff (470 g)
Number of subjects: 16
Study: 7880662

Group type: EXPERIMENTAL
Intervention: Eltanolone 4 mg ml‐1 administered at a rate of 300 ml h‐1
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Eltanolone 4 mg ml‐1 administered at a rate of 600 ml h‐1
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Eltanolone 4 mg ml‐1 administered at a rate of 1200 ml h‐1
Number of subjects: 30
Study: 2975925

Group type: EXPERIMENTAL
Intervention: Sufentanil
Number of subjects: 20

Group type: COMPARATOR
Intervention: Fentanyl
Number of subjects: 20
Study: 31222771

Group type: EXPERIMENTAL
Intervention: Hyperinsulinaemia and insulin resistance (IR)
Number of subjects: 1000
Study: 26873293

Group type: EXPERIMENTAL
Intervention: Live interactive training
Number of subjects: 63

Group type: COMPARATOR
Intervention: Web-facilitated self-study training
Number of subjects: 63
Study: 25130167

Group type: EXPERIMENTAL
Intervention: Kegel exercises with vaginal spheres, performed twice daily, 5 days/week for 6 months.
Number of subjects: 70

Group type: COMPARATOR
Intervention: Kegel exercises without vaginal spheres (control group), performed twice daily, 5 days/week for 6 months.
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Kegel exercises with vaginal spheres.
Number of subjects: 70

Group type: COMPARATOR
Intervention: Kegel exercises without vaginal spheres (control group).
Number of subjects: 70
Study: 23581277

Group type: EXPERIMENTAL
Intervention: Picosulphate/magnesium citrate (Group 1)
Number of subjects: 285

Group type: COMPARATOR
Intervention: PEG + ASC (Group 2)
Number of subjects: 285
Study: 22122814

Group type: EXPERIMENTAL
Intervention: Ibuprofen sodium dihydrate 400 mg
Number of subjects: 144

Group type: COMPARATOR
Intervention: Conventional ibuprofen 400 mg
Number of subjects: 144
Study: 19168461

Group type: EXPERIMENTAL
Intervention: Atrial natriuretic peptide (ANP) or brain natriuretic peptide (BNP) as a diuretic
Number of subjects: 272

Group type: EXPERIMENTAL
Intervention: Nesiritide
Number of subjects: 272

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 272
Study: 16765532

Group type: EXPERIMENTAL
Intervention: Intravenous L-alanyl-L-glutamine 0.4 g/kg weight/day
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 29
Study: 15288394

Group type: EXPERIMENTAL
Intervention: SA‐CST + ET
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: ET alone
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: SA‐CST alone
Number of subjects: 72

Group type: COMPARATOR
Intervention: SC
Number of subjects: 72
Study: 11736859

Group type: EXPERIMENTAL
Intervention: Oral etoposide (100 mg capsules) for 14 days
Number of subjects: 50

Group type: COMPARATOR
Intervention: Intravenous etoposide (50 mg) on day 1 or day 7
Number of subjects: 50
Study: 9416715

Group type: EXPERIMENTAL
Intervention: Routine thermal management (hypothermia)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Extra warming (normothermia)
Number of subjects: 150
Study: 7848388

Group type: EXPERIMENTAL
Intervention: 50 micrograms of fentanyl in 2 ml volume added to 0.5% bupivacaine
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 100 micrograms of fentanyl in 2 ml volume added to 0.5% bupivacaine
Number of subjects: 90

Group type: COMPARATOR
Intervention: 2 ml of saline added to 0.5% bupivacaine
Number of subjects: 90
Study: 3168642

Group type: EXPERIMENTAL
Intervention: Sad affect induction
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Angry affect induction
Number of subjects: 125
Study: 31232112

Group type: EXPERIMENTAL
Intervention: BsmI polymorphism (Bb and bb)
Number of subjects: 70

Group type: COMPARATOR
Intervention: FokI polymorphism
Number of subjects: 70
Study: 30954086

Group type: EXPERIMENTAL
Intervention: Photobiomodulation therapy (PBMT)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study: 28592454

Group type: EXPERIMENTAL
Intervention: Coated-platelet levels ≥51.1%
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Coated-platelet model
Number of subjects: 171
Study: 26700275

Group type: EXPERIMENTAL
Intervention: Telemonitoring of blood glucose, blood pressure, and weight
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Telemonitoring of blood glucose
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Telemonitoring
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Home monitoring convenience
Number of subjects: 33
Study: 22812691

Group type: EXPERIMENTAL
Intervention: Eslicarbazepine acetate (ESL) 600 mg on days 1-3 and 1,200 mg on days 4-9, once daily
Number of subjects: 14

Group type: COMPARATOR
Intervention: Oxcarbazepine (OXC) 300 mg on days 1-3 and 600 mg on days 4-9, twice daily
Number of subjects: 14
Study: 22729520

Group type: EXPERIMENTAL
Intervention: Intraoperative lymphatic mapping and sentinel node biopsy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not available
Number of subjects: 0
Study: 19419555

Group type: EXPERIMENTAL
Intervention: Amlexanox oral adhesive pellicles
Number of subjects: 216

Group type: COMPARATOR
Intervention: Amlexanox oral adhesive tablets
Number of subjects: 216

Group type: COMPARATOR
Intervention: Placebo pellicles
Number of subjects: 216
Study: 17466972

Group type: EXPERIMENTAL
Intervention: 1-desamino-8-D-arginine-vasopressin administration after water loading
Number of subjects: 20

Group type: COMPARATOR
Intervention: Water loading
Number of subjects: 20
Study: 15095796

Group type: EXPERIMENTAL
Intervention: Parent bathing under nursing supervision at the bedside
Number of subjects: 111

Group type: COMPARATOR
Intervention: Nurse bathing in an admission nursery
Number of subjects: 111
Study: 11231774

Group type: EXPERIMENTAL
Intervention: Aspirin treatment
Number of subjects: 20968

Group type: EXPERIMENTAL
Intervention: Frequent aspirin use (>/=180 days per year)
Number of subjects: 20968
Study: 9576406

Group type: EXPERIMENTAL
Intervention: Captopril (25 mg/day)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 7935702

Group type: EXPERIMENTAL
Intervention: Lovastatin (40 mg orally twice daily)
Number of subjects: 404

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 404
Study: 3428345

Group type: EXPERIMENTAL
Intervention: Carvedilol 50 mg capsule
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Carvedilol 12.5 mg i.v.
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Carvedilol 25 mg capsule
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Carvedilol 50 mg suspension
Number of subjects: 20
Study: 31930293

Group type: EXPERIMENTAL
Intervention: Prasugrel
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ticagrelor
Number of subjects: 0

Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 0
Study: 29728882

Group type: EXPERIMENTAL
Intervention: Cyanoacrylate glue with low-weight polypropylene mesh (n=216)
Number of subjects: 625

Group type: EXPERIMENTAL
Intervention: Non-absorbable sutures with partially absorbable mesh (n=207)
Number of subjects: 625

Group type: EXPERIMENTAL
Intervention: Self-gripping polyesther mesh (n=202)
Number of subjects: 625

Group type: COMPARATOR
Intervention: All groups combined
Number of subjects: 625
Study: 28623904

Group type: EXPERIMENTAL
Intervention: Multiple micronutrients (MM)
Number of subjects: 5011

Group type: EXPERIMENTAL
Intervention: Iron and folic acid (IFA)
Number of subjects: 5011

Group type: COMPARATOR
Intervention: Folic acid (FA)
Number of subjects: 5011
Study: 26394355

Group type: EXPERIMENTAL
Intervention: Enzyme-deantigenic equine bone (EDEB)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Anorganic bovine bone (ABB)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Both EDEB and ABB
Number of subjects: 40
Study: 23149081

Group type: EXPERIMENTAL
Intervention: Expectancy assessment before first infusion
Number of subjects: 91

Group type: COMPARATOR
Intervention: No expectancy assessment (control group)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Expectancy assessment
Number of subjects: 91
Study: 21681585

Group type: EXPERIMENTAL
Intervention: 200 mg BGC20-1531
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 400 mg BGC20-1531
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 18365505

Group type: EXPERIMENTAL
Intervention: Surgical sphincterotomy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Botulinum toxin injections into internal anal sphincter
Number of subjects: 60
Study: 17052565

Group type: EXPERIMENTAL
Intervention: Acetaminophen extended release 1,300 mg 3 times daily
Number of subjects: 260

Group type: COMPARATOR
Intervention: Ibuprofen 400 mg 3 times daily
Number of subjects: 260
Study: 12747651

Group type: EXPERIMENTAL
Intervention: 0.3 ml (12.5 mg) triamcinolone acetonide intravitreally
Number of subjects: 31

Group type: COMPARATOR
Intervention: 0.3 ml balanced salt solution after retrobulbar anesthesia
Number of subjects: 31
Study: 11149273

Group type: EXPERIMENTAL
Intervention: Glycoprotein IIb/IIIa antagonists (abciximab, tirofiban, eptifibatide)
Number of subjects: 0
Study: 8636902

Group type: EXPERIMENTAL
Intervention: Repressive personality and social behavior
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Psychological distancing under threat
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Processing self-relevant and non-self-relevant information
Number of subjects: 0
Study: 1592715

Group type: EXPERIMENTAL
Intervention: Arginine/Lysine supplementation (AL)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Resistance Training (RT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo/Control (P/C)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Placebo/Resistance Training (P/RT)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Arginine/Lysine/Control (AL/C)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Arginine/Lysine/Resistance Training (AL/RT)
Number of subjects: 30
Study: 2867598

Group type: EXPERIMENTAL
Intervention: RP 40 749 (150 mg)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 31211638

Group type: EXPERIMENTAL
Intervention: HyFlex EDM NiTi rotary files
Number of subjects: 60

Group type: COMPARATOR
Intervention: ProTaper Universal Retreatment NiTi Systems
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Laser activated irrigation (PIPS)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional needle irrigation
Number of subjects: 60
Study: 29636247

Group type: EXPERIMENTAL
Intervention: 7-valent pneumococcal conjugate vaccine (PCV7)
Number of subjects: 237

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 237
Study: 26260216

Group type: EXPERIMENTAL
Intervention: Specialist-led physical education (SPE) program (100 min/week of CP PE replaced by SPE)
Number of subjects: 727

Group type: EXPERIMENTAL
Intervention: Specialist-led physical education (SPE) program
Number of subjects: 727

Group type: COMPARATOR
Intervention: Common practice physical education (CP)
Number of subjects: 727
Study: 25405390

Group type: EXPERIMENTAL
Intervention: CABG plus mitral-valve repair (combined procedure)
Number of subjects: 301

Group type: COMPARATOR
Intervention: CABG alone
Number of subjects: 301
Study: 22476239

Group type: EXPERIMENTAL
Intervention: Lateral classic TAP block with 30 mL ropivacaine 0.375%
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Dual 15 mL injections at the upper intercostal and lateral classic TAP plexuses
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: All injectate areas
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Measured serum ropivacaine concentrations
Number of subjects: 8
Study: 20573492

Group type: EXPERIMENTAL
Intervention: Antiwei (6 g, twice daily for three days)
Number of subjects: 480

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 480
Study: 17785708

Group type: EXPERIMENTAL
Intervention: Supervised aerobic exercise
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: Supervised resistance exercise
Number of subjects: 242

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 242
Study: 15117415

Group type: EXPERIMENTAL
Intervention: Buprenorphine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dihydrocodeine
Number of subjects: 0
Study: 11476307

Group type: EXPERIMENTAL
Intervention: Cefuroxime-impregnated cement
Number of subjects: 78

Group type: COMPARATOR
Intervention: Cement without cefuroxime
Number of subjects: 78
Study: 9526912

Group type: EXPERIMENTAL
Intervention: Guided tissue regeneration (GTR) procedure using a bioabsorbable membrane
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Guided tissue regeneration (GTR) procedure using a non-resorbable membrane
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Mucogingival surgical approach with connective tissue graft and coronally advanced flap (bilaminar technique)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Comparison between bilaminar and non-resorbable membrane groups
Number of subjects: 54

Group type: COMPARATOR
Intervention: All treatment approaches
Number of subjects: 54

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 54
Study: 8017507

Group type: EXPERIMENTAL
Intervention: Static orthosis at night (experimental group)
Number of subjects: 13

Group type: COMPARATOR
Intervention: No static orthosis (control group)
Number of subjects: 13
Study: 2728825

Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate (ISDN) 80 micrograms/kg
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate (ISDN) 40 micrograms/kg
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (no ISDN)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: All groups (ISDN 40, ISDN 80, Control)
Number of subjects: 30
Study: 787443

Group type: EXPERIMENTAL
Intervention: Amantadine-HC1
Number of subjects: 153
Study: 31109232

Group type: EXPERIMENTAL
Intervention: Fast-track surgery (FTS)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Traditional treatments (Control)
Number of subjects: 80
Study: 27402346

Group type: EXPERIMENTAL
Intervention: Implementation strategy consisting of a working group meeting, supervisor training in PA application, and optional supervisor coaching.
Number of subjects: 116

Group type: COMPARATOR
Intervention: Written information on PA.
Number of subjects: 116
Study: 25312348

Group type: EXPERIMENTAL
Intervention: Exercise (intense exercise before or after encoding)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Exercise (intense exercise)
Number of subjects: 0
Study: 23116369

Group type: EXPERIMENTAL
Intervention: Self-reward condition
Number of subjects: 100

Group type: COMPARATOR
Intervention: Other-reward condition
Number of subjects: 100
Study: 21651447

Group type: EXPERIMENTAL
Intervention: Pitavastatin calcium 1 mg/day
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Pitavastatin calcium 2 mg/day
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (healthy subjects)
Number of subjects: 40
Study: 19657829

Group type: EXPERIMENTAL
Intervention: Individual-focused frame
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Collective-focused frame
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Joint frame
Number of subjects: 0

Group type: COMPARATOR
Intervention: No-frames control
Number of subjects: 0
Study: 16096256

Group type: EXPERIMENTAL
Intervention: Trunk Impairment Scale (TIS) for stroke patients
Number of subjects: 80

Group type: COMPARATOR
Intervention: Trunk Impairment Scale (TIS) for healthy individuals
Number of subjects: 80
Study: 12406481

Group type: EXPERIMENTAL
Intervention: Tobacco/alcohol use-prevention program
Number of subjects: 660

Group type: COMPARATOR
Intervention: Attention-control condition (first aid/home safety)
Number of subjects: 660
Study: 10559769

Group type: EXPERIMENTAL
Intervention: Continuous MF exposure (100 mu T(rms) 50 Hz for 30 minutes)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Intermittent MF exposure (100 mu T(rms) 50 Hz for 30 minutes, 15 s ON/OFF cycles)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Real MF exposure (100 mu T(rms) 50 Hz for 30 minutes)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Sham exposure (control)
Number of subjects: 21
Study: 7576669

Group type: EXPERIMENTAL
Intervention: Intraoperative hypothermia (approximately 2.5 degrees C hypothermic)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Normothermic patients
Number of subjects: 74
Study: 2156277

Group type: EXPERIMENTAL
Intervention: 50 mg/kg L-tryptophan administered intravenously over 20 min
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: 50 mg/kg L-tryptophan
Number of subjects: 25
Study: 378348

Group type: EXPERIMENTAL
Intervention: Oophorectomy + vincristine, prednisone, cyclophosphamide, methotrexate, 5‐fluorouracil (VPCMF)
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Oophorectomy + cyclophosphamide
Number of subjects: 157

Group type: COMPARATOR
Intervention: Oophorectomy followed by an observation period (Phase 1), followed by VPCMF (Phase 2)
Number of subjects: 157
Study: 31769161

Group type: EXPERIMENTAL
Intervention: Firehawk stent
Number of subjects: 1585

Group type: COMPARATOR
Intervention: XIENCE stent
Number of subjects: 1585
Study: 31842992

Group type: EXPERIMENTAL
Intervention: Inverted syringe technique
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 100
Study: 27427181

Group type: EXPERIMENTAL
Intervention: Praat acoustic analysis
Number of subjects: 182
Study: 25836591

Group type: EXPERIMENTAL
Intervention: Ischemic Compression (IC)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Dry needling + Ischemic Compression (IC)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control
Number of subjects: 90
Study: 23775877

Group type: EXPERIMENTAL
Intervention: Aprepitant
Number of subjects: 16

Group type: COMPARATOR
Intervention: Alcohol
Number of subjects: 16

Group type: COMPARATOR
Intervention: Amitriptyline
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Aprepitant + Alcohol
Number of subjects: 16
Study: 21762225

Group type: EXPERIMENTAL
Intervention: TPI ASM8 (4 mg b.i.d.)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: TPI ASM8 (8 mg o.d.)
Number of subjects: 14
Study: 19817982

Group type: EXPERIMENTAL
Intervention: Sildenafil 100 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sildenafil 50 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 17348884

Group type: EXPERIMENTAL
Intervention: Transmucosal implant placement (test group)
Number of subjects: 10
Study: 14732421

Group type: EXPERIMENTAL
Intervention: Social reinforcement of aftercare group therapy attendance
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard aftercare orientation
Number of subjects: 40
Study: 11230791

Group type: EXPERIMENTAL
Intervention: Simvastatin 20 mg
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study: 9756584

Group type: EXPERIMENTAL
Intervention: rtPA treatment
Number of subjects: 615

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 615
Study: 8148045

Group type: EXPERIMENTAL
Intervention: Cisapride and postural dietetic limits
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Domperidone and postural dietetic limits
Number of subjects: 55

Group type: COMPARATOR
Intervention: Postural dietetic limits only
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Overall treatment (both interventions)
Number of subjects: 55
Study: 3075625

Group type: EXPERIMENTAL
Intervention: Timolol 0.5% twice daily
Number of subjects: 22

Group type: COMPARATOR
Intervention: Contralateral eyes (no treatment)
Number of subjects: 22
Study: 31357206

Group type: EXPERIMENTAL
Intervention: Baclofen
Number of subjects: 12

Group type: COMPARATOR
Intervention: l-DOPA
Number of subjects: 12

Group type: COMPARATOR
Intervention: Dextromethorphan
Number of subjects: 12

Group type: COMPARATOR
Intervention: Rivastigmine
Number of subjects: 12

Group type: COMPARATOR
Intervention: Baseline
Number of subjects: 12
Study: 29417288

Group type: EXPERIMENTAL
Intervention: Antimicrobial lubricant instilled prior to biopsy
Number of subjects: 384

Group type: COMPARATOR
Intervention: Standard lubricant
Number of subjects: 384

Group type: EXPERIMENTAL
Intervention: Overall population
Number of subjects: 384
Study: 27068870

Group type: EXPERIMENTAL
Intervention: 300 UA/day
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: 1000 UA/day
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: 2000 UA/day
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: 3000 UA/day
Number of subjects: 131

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 131
Study: 25056766

Group type: EXPERIMENTAL
Intervention: Tension-free vaginal tape (TVT) procedure
Number of subjects: 128

Group type: COMPARATOR
Intervention: Laparoscopic mesh colposuspension (LCM)
Number of subjects: 128
Study: 24163815

Group type: EXPERIMENTAL
Intervention: Group B (urethra preserved until the level of verumontanum)
Number of subjects: 329

Group type: COMPARATOR
Intervention: Group A (standard radical prostatectomy)
Number of subjects: 329

Group type: EXPERIMENTAL
Intervention: Group B
Number of subjects: 329

Group type: COMPARATOR
Intervention: Group A
Number of subjects: 329
Study: 21079818

Group type: EXPERIMENTAL
Intervention: Atorvastatin (ATO) 40 mg/day
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14